Clinical Trial: Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711964) titled 'Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome' on June 29, 2025.

Brief Summary: The early phase of Acute Respiratory Distress Syndrome (ARDS) is characterized by intense alveolar inflammation. Corticosteroids have been used to treat ARDS for decades. Although their efficacy has been a subject of ongoing controversy, recent clinical practice guidelines for ARDS issued a weak recommendation in favor of corticosteroid use in early ARDS. However, the optimal dose and duration of corticosteroid therapy remain unclear. Low-dose, short-course regimens have been evaluated in clinical trials for...